Example collocations logo

Regulatory in sentence

1413 examples of Regulatory in a sentence

Companies can sue governments for full compensation for any reduction in their future expected profits resulting from regulatory changes.
And an abundance of policy and regulatory uncertainties will keep private investment spending in check.
The downside risks result from political gridlock in Congress (particularly given the upcoming midterm election in November), which will continue to limit progress on long-term fiscal consolidation; a lack of clarity about the Federal Reserve’s planned exit from quantitative easing (QE) and zero policy rates; and regulatory uncertainties.
This would create a European regulatory regime.
The salary, which can be paid entirely in cash, will be renegotiated every year, thereby skirting all the regulatory restrictions.
The feature of the proposed pact that elicits the most excitement – its focus on regulatory barriers like mandatory product standards – should actually incite the greatest concern.
Second, where they do consider harmonization, they could favor the less stringent of the original standards, unless there is credible evidence that it would not support the relevant regulatory objective.
Research reveals that strong enforcement of property rights and stable, predictable, and non-confiscatory tax and regulatory regimes are essential to long-run economic prosperity.
Decisions about data-center specifications are important for managing costs, obtaining a reliable supply of energy and water, and lowering reputational risks, particularly given the increasing global regulatory focus on climate change.
The most obvious suspect is Basel III, the new global regulatory standard for banks’ capital adequacy and liquidity.
A more feasible solution would be to introduce an explicit regulatory bias against home-country sovereign-debt holdings.
And the regulatory failures in Europe – consider the German Landesbanks, for example – will become only more obvious in the coming months.
Serious independent analysis, for example by the World Bank or the Organization for Economic Cooperation and Development, finds that the US does not have a high regulatory burden on the non-financial sector.
This is because body weight is the sum of our organs and body tissues; and each organ or body part has its own regulatory (and thus partly genetic) basis.
Indeed, the regulation of body weight overall is determined by the sum of the specific regulatory outcomes affecting individual body components.
Having said this, there would be immediate upside potential, owing to better resource allocation, more harmonized investment regimes, stronger standards, and the elimination of outdated non-tariff and regulatory barriers.
For the government, the imperative is to create more regulatory space and provide a facilitating ethos for the private sector.
Or has post-crisis regulatory reform done its job?
And more regulatory changes are in the works.
The third reason to be wary of bankers’ confidence that the regulatory job is complete is that once they believe it, they will behave accordingly – less frightened of failure and thus willing to take on more risk.
South Australia, meanwhile, has developed the most supportive regulatory framework for renewable energy investment in Australia, enabling an increase in renewables’ share in power generation from virtually zero in 2003 to almost 40% today.
The development of regulatory frameworks that encourage competition would also help, as would limiting tax-base erosion.
And regulatory intervention powers are far more robust.
As former US Federal Reserve board chair Paul Volcker has observed, “virtually every post-mortem of the financial crisis cites the convoluted regulatory system [in the US] as a contributory factor in the financial meltdown.”
Nine years after its creation, despite its vast potential to benefit humanity – and a negligible probability of harm to human health or the environment – Golden Rice remains hung up in regulatory red tape, with no end in sight.
Judith Rodin, the president of the Rockefeller Foundation, announced last October that her organization will provide funding to the International Rice Research Institute to shepherd Golden Rice through national regulatory approval processes in Bangladesh, India, Indonesia, and the Philippines.
This is good news, but what is really needed is a multi-faceted, aggressive reform of the regulatory process so that all new genetic constructions will have a chance to succeed.
In an April editorial in the journal Science , Nina Fedoroff, an eminent plant geneticist who serves as senior scientific advisor to US Secretary of State Condoleezza Rice, wrote: “A new Green Revolution demands a global commitment to creating a modern agricultural infrastructure everywhere, adequate investment in training and modern laboratory facilities, and progress toward simplified regulatory approaches that are responsive to accumulating evidence of safety.
Greece’s heavy regulatory burden, well described by the World Bank’s indicators on the ease of doing business, represents a significant entry barrier in many sectors, effectively closing off entire industries and occupations to competition.
Since 2001-2002, the pharmaceutical sector has spent $1.1 trillion on research and development, but the 12 largest companies have received regulatory approval for only 139 new molecular compounds.
BackNext